Conversely, the Vascular Endothelial Growth Factor (VEGF) levels were notably lower in the CAD patients, including those with a CTO (p = 0.001), potentially reflecting a disrupted endothelial response in chronic coronary syndromes. The gene discussed is VEGFA; the disease is coronary artery disorder.